您当前所在位置:首页 > 定制产品 > 新品上市
序号 标题 次数 作者 发布时间
62371 MC-Val-Cit-PAB-tubulysin5a ,CAS号:2055896-86-9 60 WYQ 2024-12-19
62372 Au_55_C11NH3Cl 金55-C11-NH3Cl 90 h 2024-12-19
62373 (S-(CH2)11-(beta-Lactose(SO4Na)7)2 硫-十一烷烃-β-乳糖 109 h 2024-12-19
62374 HS-(CH2)11-O-Disperse Red 1 十一烷烃硫醇化荧光配体 152 h 2024-12-19
62375 HS-(CH2)16-(EG)2 -N(+)(CH3)2-CH2-COO(-) 二聚乙二醇化十六硫醇 112 h 2024-12-19
62376 cas:103750-03-4,5-Maleimido-pentanoic NHS ester,5-马来酰亚胺戊酸NHS 113 kx 2024-12-19
62377 4-Nitrophenyl 2-(pyridin-2-yldisulfanyl)propyl carbonate,抗体药物偶联物(ADC) 113 kx 2024-12-19
62378 cas:158913-22-5,SPDP-C6-NHS ester,琥珀酰亚胺基6-[3-(2-吡啶基二硫代)丙酰胺基]己酸酯 103 kx 2024-12-19
62379 perfluorophenyl 4-methyl-4-(pyridin-2-yldisulfanyl)pentanoate,抗体药物偶联物(ADC) 117 kx 2024-12-19
62380 cas:663598-61-6,2,5-dioxopyrrolidin-1-yl 4-((5-nitropyridin-2-yl)disulfanyl)pentanoate, ADC试剂 90 kx 2024-12-19
62381 perfluorophenyl 4-(pyridin-2-yldisulfanyl)butanoate, ADC试剂 74 kx 2024-12-19
62382 cas:160580-70-1,perfluorophenyl 3-(pyridin-2-yldisulfanyl)propanoate,抗体药物偶联物(ADC) 112 kx 2024-12-19
62383 cas:252554-78-2, Fmoc-Ala-Ser(Psi(Me Me)pro)-OH,(4S)-3-[(2S)-2-[[(9H-芴-9-甲氧基)羰基]氨基]-1-氧代丙基]-2,2-二甲基-4-恶唑烷羧酸 131 kx 2024-12-19
62384 MC-Val-Cit-PAB-Indibulin, cas:2055896-95-0 79 WYQ 2024-12-19
62385 cas:1884578-27-1 ,Alloc-Val-Ala-PAB-PNP,N-[(2-丙烯-1-基氧基)羰基]-L-缬氨酸-N-[4-[[(4-硝基苯氧基)羰基]氧基]甲基]苯基]-L-丙氨酸酰胺 91 kx 2024-12-19
62386 mDPR-Val-Cit-PAB-MMAE(CAS:1491152-26-1) 79 WYQ 2024-12-19
62387 2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate 88 wyh 2024-12-19
62388 MC-Val-Cit-PAB-vinblastine(CAS:2055896-92-7) 83 WYQ 2024-12-19
62389 2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate 64 wyh 2024-12-19
62390 MC-Val-Cit-PAB-tubulysin5a(CAS:2055896-86-9) 86 WYQ 2024-12-19
62391 N-芴甲氧羰基-四聚乙二醇-VAL-ALA-PAB, Fmoc-PEG4-Val-Ala-PAB 113 kx 2024-12-19
62392 MC-Val-Cit-PAB-clindamycin(CAS号:1639793-13-7) 74 WYQ 2024-12-19
62393 MC-Val-Cit-PAB-carfilzomib,CAS号:2055896-83-6 96 WYQ 2024-12-19
62394 叔丁酯-四聚乙二醇-VAL-ALA-PAB,Boc-PEG4-Val-Ala-PAB 69 kx 2024-12-19
62395 MC-Val-Cit-PAB-Auristatin E,CAS号:2055896-77-8 95 WYQ 2024-12-19
62396 MC-Sq-Cit-PAB-Gefitinib(CAS:1941168-63-3) 148 WYQ 2024-12-19
62397 HS-(CH2)m-(EG)n -N(+)(CH3)2-CH2-COO(-) 聚乙二醇化直链烷烃硫醇 85 h 2024-12-19
62398 Mal-PEG4-Val-Ala-PAB,马来酰亚胺-四聚乙二醇-VAL-ALA-PAB 119 kx 2024-12-19
62399 MC-GGFG-DX8951(CAS:1600418-29-8) 252 WYQ 2024-12-19
62400 (HO)2-PO-S-(CH2)6-EG2-OH 硫-(2-羟基六烷-1-基)硫代磷酸酯 117 h 2024-12-19
62401 Au_55_C11EG4Carboxybetaine 金团簇55-羧基甜菜碱 107 h 2024-12-19
62402 (HO)2-PO-S-(CH2)m-COONHS 硫-(2,5-二氧代 - 吡咯烷-1-基氧基羰基)-1-基硫代磷酸 88 h 2024-12-19
62403 2529982-76-9,Azido-PEG4-Val-Ala-PAB,叠氮-四聚乙二醇-VAL-ALA-PAB 99 kx 2024-12-19
62404 Au_12_C11EG6 金团簇12-直链烷烃六聚乙二醇 108 h 2024-12-19
62405 cas:863971-17-9 ,MC-Val-Cit-PAB-MMAF,MC-VAL-CIT-PAB-MMAF游离态 74 kx 2024-12-19
62406 CF3-(CF2)5-C2-O-C11-Si(OMe)3 巯基-直链烷烃连接氟化硫醇和硅烷 92 h 2024-12-19
62407 cas:2353409-69-3 , Mal-PEG8-Val-Cit-PAB-MMAE,马来酰亚胺-八聚乙二醇-VAL-CIT-PAB-MMAE 66 kx 2024-12-19
62408 cas:2129164-91-4 , DBCO-PEG4-Val-Cit-PAB-MMAE,二苯并环辛炔-四聚乙二醇-VAL-CIT-PAB-MMAE 141 kx 2024-12-19
62409 MAL-di-EG-Val-Cit-PAB-MMAF,由ADC连接桥(MAL-di-EG-Val-Cit-PAB)和有效的微管蛋白聚合阻断剂(MMAF, Monomethyl auristatin F)组成 109 WYQ 2024-12-19
62410 MAL-di-EG-Val-Cit-PAB-MMAE,CAS编号:2746391-62-6 111 WYQ 2024-12-19
62411 cas:644981-35-1 , Val-Cit-PAB-MMAE, ADC试剂 66 kx 2024-12-19
62412 cas:2754384-60-4,DBCO-(PEG)3-VC-PAB-MMAE,抗体药物偶联物(ADC) 119 kx 2024-12-19
62413 AcLys-PABC-VC-Aur0101(CAS:1438851-17-2) 91 WYQ 2024-12-19
62414 反式环辛烯-MMAE,TCO-MMAE, ADC试剂 116 kx 2024-12-19
62415 Hydrazone-doxorubicin,阿霉素-腙键偶联物 150 WYQ 2024-12-19
库存查询